| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Release in Lipopolysaccharide-Stimulated Human Monocytes Through TGF-
1
* Experimental Medicine Unit and
Ludwig Institute for Cancer Research, Christian de Duve Institute of Cellular Pathology, and
Laboratory of Hematology, Université de Louvain, Brussels, Belgium
IL-9 is a Th2 cytokine that exerts pleiotropic activities on T
cells, B cells, mast cells, hematopoietic progenitors, and lung
epithelial cells, but no effect of this cytokine has been reported so
far on mononuclear phagocytes. Human blood monocytes preincubated with
IL-9 for 24 h before LPS or PMA stimulation exhibited a decreased
oxidative burst, even in the presence of IFN-
. The inhibitory effect
of IL-9 was specifically abolished by anti-hIL-9R mAb, and the
presence of IL-9 receptors was demonstrated on human blood monocytes by
FACS. IL-9 also down-regulated TNF-
and IL-10 release by
LPS-stimulated monocytes. In addition, IL-9 strongly up-regulated the
production of TGF-
1 by LPS-stimulated monocytes. The suppressive
effect of IL-9 on the respiratory burst and TNF- production in
LPS-stimulated monocytes was significantly inhibited by
anti-TGF-1, but not by anti-IL-10R mAb. Furthermore, IL-9
inhibited LPS-induced activation of extracellular signal-regulated
kinase 1/2 mitogen-activated protein kinases in monocytes through a
TGF--mediated induction of protein phosphatase activity. In
contrast, IL-4, which exerts a similar inhibitory effect on the
oxidative burst and TNF- release by monocytes, acts primarily
through a down-regulation of LPS receptors. Thus, IL-9 deactivates
LPS-stimulated blood mononuclear phagocytes, and the mechanism of
inhibition involves the potentiation of TGF-1 production and
extracellular signal-regulated kinase inhibition. These findings
highlight a new target cell for IL-9 and may account for the beneficial
activity of IL-9 in animal models of exaggerated inflammatory
response.
This article has been cited by other articles:
|
|
 |
|
  P. D. A. Issuree, P. N. Pushparaj, S. Pervaiz, and A. J. Melendez Resveratrol attenuates C5a-induced inflammatory responses in vitro and in vivo by inhibiting phospholipase D and sphingosine kinase activities FASEB J, August 1, 2009; 23(8): 2412 - 2424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Keino, S. Masli, S. Sasaki, J. W. Streilein, and J. Stein-Streilein CD8+ T Regulatory Cells Use a Novel Genetic Program that Includes CD103 to Suppress Th1 Immunity in Eye-Derived Tolerance. Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1533 - 1542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. von Knethen, A. Tautenhahn, H. Link, D. Lindemann, and B. Brune Activation-Induced Depletion of Protein Kinase C{alpha} Provokes Desensitization of Monocytes/Macrophages in Sepsis J. Immunol., April 15, 2005; 174(8): 4960 - 4965. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Matsumura, H. Hayashi, T. Takii, C. F. Thorn, A. S. Whitehead, J.-i. Inoue, and K. Onozaki TGF-{beta} down-regulates IL-1{alpha}-induced TLR2 expression in murine hepatocytes J. Leukoc. Biol., June 1, 2004; 75(6): 1056 - 1061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Dai, S. Datta, M. Novotny, and T. A. Hamilton TGF{beta} inhibits LPS-induced chemokine mRNA stabilization Blood, August 15, 2003; 102(4): 1178 - 1185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Pilette, Y. Ouadrhiri, J. Van Snick, J-C. Renauld, P. Staquet, J-P. Vaerman, and Y. Sibille Oxidative burst in lipopolysaccharide-activated human alveolar macrophages is inhibited by interleukin-9 Eur. Respir. J., November 1, 2002; 20(5): 1198 - 1205. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
